Brief: India's Marksans Pharma Sept-Qtr Consol Profit Rises
12/11/2019 10:39
Nov 12 (Reuters) - Marksans Pharma Ltd MARK.NS :
* SEPT QUARTER CONSOL PROFIT 259.7 MILLION RUPEES VERSUS
205.7
MILLION RUPEES YEAR AGO
* SEPT QUARTER CONSOL REVENUE FROM OPERATIONS 2.56 BILLION
RUPEES
VERSUS 2.69 BILLION RUPEES YEAR AGO
Source text for Eikon: ID:nBSE82cfB2
Further company coverage: MARK.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Marksans Pharma
See all newsIndia's Marksans Pharma jumps to over 18-month high after more than doubling quarterly profit
Brief: Marksans Pharma Ltd To Acquire 100% Of Netherlands-Based Qliniq B.V
India's Marksans Pharma jumps to 10-month high after Q4 profit rise
Brief: Marksans Pharma March-Quarter Consol Net Profit 1.48 Billion Rupees
Brief: Marksans Pharma Ltd Receives USFDA Approval For Benzonatate Capsules USP, 100 Mg & 200 Mg